CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Heat Shock Protein Inhibitors Tyrosine Kinase Inhibitors EGFR | Urothelial Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Colorectal Cancer | Penile Cancer | Squamous Cell Skin Cancer | Small Cell Lung Cancer | Soft Tissue Sarcoma | Lung Cancer |
---|---|---|---|---|---|---|---|---|---|
atezolizumab | |||||||||
pembrolizumab | |||||||||
nivolumab | |||||||||
nivolumab + pimitespib | |||||||||
anlotinib + sintilimab | |||||||||
sintilimab | |||||||||
nivolumab + ipilimumab | |||||||||
toripalimab-tpzi | |||||||||
pembrolizumab + panitumumab | |||||||||
durvalumab + tremelimumab | |||||||||
anlotinib + toripalimab-tpzi | |||||||||
Immunotherapy |